← Open Payments lookup

NATALIE PEARSON: Open Payments

NPI 1740673862 · CENTRAL CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$419 in 23 payments from 13 companies in 2025. Trend: 2023 $198 · 2024 $155 · 2025 $419

Food & beverage: $419
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$49
E.R. Squibb & Sons, L.L.C.3$46
VERTEX PHARMACEUTICALS INCORPORATED2$40
Otsuka America Pharmaceutical, Inc.2$35
Novo Nordisk Inc2$31
AstraZeneca Pharmaceuticals LP2$31
Ardelyx, Inc.1$26
Viatris Specialty LLC1$23
Janssen Pharmaceuticals, Inc1$22

Products named: CAPLYTA, UZEDY, REXULTI, ELIQUIS, IBSRELA, YUPELRI, AUSTEDO XR, INVEGA SUSTENNA.

Industry payments across NE — which companies pay providers there.